Codes of Conduct


The mission of EFPIA and, implicitly, of ARPIM is to promote the progresses in the pharmaceutical industry due to its technological and economic development in Europe and to assist in bringing to market medicinal products, representing the fruits of the scientific research, in order to improve human health worldwide.


Promotion and dissemination of scientific and educational information ensure that the results of years of scientific work and huge investments in research and development shall also be made available to the healthcare professionals and to the patients worldwide. In all healthcare-related activities the representatives of the pharmaceutical industry believe that high standards should be defined and observed and are convinced that, as far as its marketing activities are concerned, selfdiscipline is the process which best serves the public interest. Ethical criteria for promotion of medicinal products are regarded as the foundation for proper behavior, consistent with the search for truthfulness and righteousness.

In January 2007 Romania became an EU member. In order to apply the same high ethical standards for promotional activities performed by the pharmaceutical industry in the EU, it is mandatory to implement in Romania a code of conduct similar to the one applied in the EU countries. The ARPIM Ethical Code in Drugs Promotion shall represent a reference that should thus assist in judging if promotional practices related to medicinal drugs are in keeping with acceptable ethical standards.

ARPIM is conscious of the importance of providing accurate, fair and objective information about medicinal products so that rational decisions can be made as to their use. Considering that, ARPIM has adopted in May 2005 the ARPIM Code of Practice on the Promotion of Medicines (the “ARPIM Code”). The ARPIM Code reflects the requirements of the EFPIA Code and Council Directive 2001/83/EC1 , as amended, relating to medicinal products for human use (the “Directive”). The ARPIM Code fits into the general framework established by the Directive, which recognizes the role of voluntary control of advertising of medicinal products by self-regulatory bodies and recourse to such bodies when complaints arise.

ARPIM encourages competition among pharmaceutical companies. The ARPIM Code is not intended to restrain the promotion of medicinal products or to limit the interaction with professionals from healthcare field in a manner that is detrimental to fair competition. Instead, it seeks to ensure that the promotional activities and other related activities are performed in a truthful manner, avoiding deceptive practices and potential conflicts of interest with healthcare professionals, and in compliance with Romanian laws and regulations. The ARPIM Code thereby aims to foster an environment where the general public can be confident that choices regarding their medicines are being made on the basis of the merits of each product and the healthcare needs of patients.